Aktie A1KBBJ KIDSWELL BIO CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Kidswell Bio Corporation

Aktien

A1KBBJ

JP3386460004

4584

Verzögert Japan Exchange
Andere Börsenplätze
 05:51:35 07.05.2024 		% 5 Tage % 1. Jan.
139 JPY +2,21 % Intraday Chart für Kidswell Bio Corporation +0,72 % +3,73 %
2022 Japan Index trimmt Gewinne aufgrund von Inflationsdruck; Dena übernimmt Mehrheitsbeteiligung an Mobile ICT Business für $230 Millionen MT
2021 Kidswell Bio Corporation meldet Ergebnis für das Halbjahr bis zum 30. September 2021 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Kidswell Bio Corporation announced that it has received ¥22.8 million in funding from CVI Investments, Inc.
Kidswell Bio Corporation announced that it expects to receive ¥22.8 million in funding from CVI Investments, Inc.
Kidswell Bio Corporation(TSE:4584) dropped from S&P Global BMI Index
Japan Index Trims Gains over Inflationary Pressures; Dena to Take Majority Stake in Mobile ICT Business for $230 Million
Chiome Bioscience, Kidswell Bio to Collaborate on Development of Cancer Antibody
Kidswell Bio Corporation Reports Earnings Results for the Half Year Ended September 30, 2021
Kidswell Bio Corporation(TSE:4584) added to S&P Global BMI Index
Gene Techno Science : Announcement of Joint Research Agreement with Hokkaido University and Spinal Injuries Center for Non-Union Fractures
Gene Techno Science Co.,Ltd. Reports Earnings Results for the Year Ended March 2020
Dojin Group Co., Ltd. entered into a share transfer agreement to acquire Advanced Cell Technology and Engineering Ltd. from Gene Techno Science Co.,Ltd. for ¥0.
Gene Techno Science : Announcement of completion of issuance of the 3rd series of convertible bond with stock acquisition rights
Gene Techno Science Co.,Ltd. announced that it has received ¥604.852632 million in funding from CVI Investments, Inc.
Gene Techno Science Co.,Ltd. announced that it expects to receive ¥604.852632 million in funding from CVI Investments, Inc.
Gene Techno Science Enters into Research Agreement with Nagoya University
Gene Techno Science Co., Ltd Has Executes A Joint Research Agreement with Oita University
Gene Techno Science Co.,Ltd. acquired remaining 94.7% stake in Japan Regenerative Medicine Co., Ltd. from Noritsu Koki Co., Ltd. for ¥0.
Gene Techno Science : Signed alliance agreement with Eil for business development in regenerative medicine and healthcare area
Gene Techno Science : Announcement of Joint Research Agreement for New Antibodies with MabGenesis Inc.
Gene Techno Science : Announcement of Joint Development Agreement of Aflibercept Biosimilars with Kishi Kasei Co., Ltd.
Gene Techno Science Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1KBBJ Aktie
  4. Nachrichten Kidswell Bio Corporation
  5. Andere Sprachen